Skip to main content

IMMUTEP Ltd

IMMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001506184

No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.

Other share classesPRRUF

Q1 2023 vs. Q4 2022

How the institutions holding IMMUTEP Ltd changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of IMMP: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders2519−6
Shares4.14M2.96M−1.18M (−28.5%)
Value$7.25M$4.95M−$2.30M (−31.7%)

New holders (2)

Institutions that held IMMUTEP Ltd at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to IMMP in Q1 2023
InstitutionSharesValue% of portfolio
XY Capital Ltd13,949$23.4K0.02%
Hantz Financial Services, Inc.10$00.00%

Sold out (8)

Institutions that held IMMUTEP Ltd at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of IMMP in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Artal Group S.A.1,000,000$1.75M
Jane Street Group, LLC21,785$38.1K
Virtu Financial LLC11,926$21.0K
HighTower Advisors, LLC10,000$18.0K
Simplex Trading, LLC2,514$4.00K
UBS Group AG1,353$2.37K
National Bank of Canada300$525
Citigroup Inc58$102